-
Government digging into Tamiflu stockpile to combat flu; unfortunately evidence that the drug works as purported by drug company is being questioned
Madely Health Headlines Commentary for January 10, 2013 [display_podcast] Source: Scandal of the poison pen-pushers: How doctors and patients are kept in the dark about potentially dangerous everyday drugs
-
Deleting the clock gene in mouse fat cells leads to obesity and normal eating schedule timing
Madely Health Headlines Commentary for November 16, 2012 [display_podcast] Source: When You Eat Is Just As Crucial As What You Eat Reference: Obesity in mice with adipocyte-specific deletion of clock component Arntl
-
Man with "locked-in" brain injury able to answer questions through functional MRI
Madely Health Headlines Commentary for November 14, 2012 [display_podcast] Source: Doctors shocked as neuroscientist ‘talks’ with man in vegetative state
-
New cancer biomarker protein may lead to development of early detection and treatment
Madely Health Headlines Commentary for November 8, 2012 [display_podcast] Source: One test may ‘find many cancers’ Reference: The DSB Biomarkers Pilot Study
-
Unpublished pharma data states it has Hep C treatment cure rate of 99 percent
Madely Health Headlines Commentary for October 16, 2012 [display_podcast] Source: Abbott Labs rises on hepatitis C drug data Reference: This press release does not cite published studies. Nor do we know if there were negative outcomes in other clinical trials. THere is no obligation on the part of pharma to release details of stiudies that…
-
Post heart attack stem cell treatment study to start in February 2013
Madely Health Headlines Commentary for October 4, 2012 [display_podcast] Source: Researchers poised to test stem cells for treating damaged hearts
-
Targeted chemotherapy for HER2 breast cancer patients shows good results in phase 3 study
Madely Health Headlines Commentary for October 3, 2012 [display_podcast] Source: Breast cancer treatment targets tumours with few side effects Reference: Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
-
Major cancer research drive at MD Anderson
Madely Health Headlines Commentary for September 21, 2012 [display_podcast] Source: Largest cancer center in US launches major initiative to cure 8 forms of the disease
-
Two studies demonstrate efficacy of experimental MS medication
Madely Health Headlines Commentary for September 20, 2012 [display_podcast] Source: Experimental MS drug shown to reduce relapses: studies Reference: Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis